Orasi Medical Partners With Biogen Idec to Use Its Novel Biomarker Technology

Orasi and Biogen Idec collaborate to develop novel magnetoencephalography (MEG)- based biomarkers for CNS disorders. The non-invasive MEG scans will provide information on patient brain activity in real time and is expected to help correlate disease progression and assess drug effects.

Click here to read more.

Share this: